An integrative genomic analysis demonstrated that CSB expression is upregulated in breast cancer, and that there is a 30–300% increased risk of breast cancer conferred by six different ERCC6 variations, one of which is in the 3′ UTR and may affect miRNA binding [135]. Here, ERCC6 is linked to breast carcinoma.